Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | NFE2L3 |
| Upstream (Parents) |
|---|
| (<<) PGR → NFE2L3 |
| (<<) PITX1 → NFE2L3 |
| (<<) STAT1 → NFE2L3 |
| (<<) SMAD9 → NFE2L3 |
| (<<) RUNX1T1 → NFE2L3 |
| (<<) EBF1 → NFE2L3 |
| (<<) IRF7 → NFE2L3 |
| (<<) ZNF277 → NFE2L3 |
| (<<) IRF1 → NFE2L3 |
| (<<) EPAS1 → NFE2L3 |
| (<<) RUNX3 → NFE2L3 |
| (<<) BATF2 → NFE2L3 |
| (<<) ZNF167 → NFE2L3 |
| (<<) ETS2 → NFE2L3 |
| (<<) ETV7 → NFE2L3 |
| (<<) ZNF138 → NFE2L3 |
| (<<) RELB → NFE2L3 |
| Downstream (Children) |
|---|
| NFE2L3 → NFIA (>>) |
| NFE2L3 → ZNF91 (>>) |
| NFE2L3 → SIX2 (>>) |
| NFE2L3 → FOXC1 (>>) |
| NFE2L3 → SMAD6 (>>) |
| NFE2L3 → LZTS1 (>>) |
| NFE2L3 → ELF4 (>>) |
